Nit Happens: A Primer on Lice

Tags

, ,

By Oyinwa Alex-Okoh

Oyinwa Alex-OkohIt is that time of the year again, when students are winding down the summer vacation and anticipating the start of the new school year. Unfortunately, back to school season correlates with head lice season, and it is important to arm ourselves, as well as our kids, with defensive measures to avoid getting infested by these dreaded bugs! Head lice infestations are most commonly found in children ages 3-11, and the Center for Disease Control estimates that up to 12 million people are affected each year in the United States. Continue reading

Welcome to Back to School Week!

Tags

,

By Diane Ivey

Diane IveyAs summer turns into autumn, students are returning to classrooms across the country. Whether they’re grabbing a backpack and lunchbox on the way to elementary school, or driving to a lab to complete a Ph.D., the time has come to begin a new academic year.

Everyone loves a fresh start, and even if you’re no longer a student, “Back to School” means more than just discounts at the department store. It’s a time to sharpen your pencils, open your notebooks, and pretend (at least for a time) that you’re ahead of the game in an ever-hectic world.

This week, the AAPS Blog celebrates Back to School with posts on topics students of any age might encounter. We’ve got a great piece on head lice, as well as one about surviving graduate school, and even a post about the benefits of red wine and chocolate. (Parents, we know your secret!)

Enjoy Back to School week, and don’t forget to comment on our posts, and even submit one yourself.

Diane Ivey is the Web Content Manager at AAPS and a member of the AAPS Blog team with four years of experience in association website management. She holds a master’s in Public Affairs Reporting from the University of Illinois Springfield and a bachelor’s in journalism from Michigan State University.

Enhanced Approaches for Development and Utilization of Analytical Procedures

Tags

, , , ,

By Kenneth Norris

Ken NorrisFor the past several years, AAPS and its Analysis and Pharmaceutical Quality (APQ) section have been discussing quality by design (QbD). A QbD approach to drug development requires that quality be designed into the product. As in the development of products and production processes, a QbD framework can also be applied to analytical methods. The APQ section started this discussion back in 2008 at an open forum titled Application of Principles of QbD to Analytical Methodologies, Specification and Control Strategies. Continue reading

Happy Birthday to the AAPS Blog! Are You a PharmaStar?

Tags

, ,

Today marks the second birthday of the AAPS Blog! This blog was launched to provide pharmaceutical scientists and others interested in the field a forum in which to share their perspectives and discuss them with a broad audience. In two years, we have published 273 pieces that have received over 93,000 views worldwide by readers, many of whom engage in discussion about the pieces via the blog’s comments.

Thanks to all our contributors, readers, and commenters for your continuing support! To celebrate our birthday, please enjoy this poem by AAPS Blog Committee Chair Robert Bell. We would like to dedicate it to all our blog readers, the true PharmaStars.

Continue reading

The Nose Knows: Nose to Brain Targeting Mechanism and Recent Advances

Tags

, , ,

By Rakesh Gollen

Rakesh GollenBiologics represents a new category of drugs that have rapidly gained momentum in the past decade, as drugs of biological origin are increasing in the pharmaceutical arena. Peptides and proteins have become the drugs of choice for the treatment of numerous diseases due to their incredible selectivity and their ability to provide effective and potent action. In general, they cause few side effects, are highly specific, present limited interferences with normal biological processes, have low immunogenicity, and have great potential to cure diseases rather than merely to treat the symptoms. Apart from these benefits, from a business point of view, they hasten clinical development, and thus approval time, and they enjoy greater patent protection. Continue reading

Follow

Get every new post delivered to your Inbox.

Join 164 other followers